guest Cyprus Company Formation Dec 30, 2008 13,766 35 48 75 Jan 27, 2011 #1 Jan 27, 2011 #1 Bristol-Myers Squibb Co., whose top- selling blood thinner Plavix faces generic competition next year, said fourth-quarter profit decreased 41 percent, missing analyst estimates after one-time tax charges from restructuring. More...
Bristol-Myers Squibb Co., whose top- selling blood thinner Plavix faces generic competition next year, said fourth-quarter profit decreased 41 percent, missing analyst estimates after one-time tax charges from restructuring. More...